Home › Therapeutic areas › Metabolic › Phenylketonuria

Phenylketonuria (4 companies)

Companies with an active program in Phenylketonuria.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AGIO Agios Pharmaceuticals HematologyMetabolic Rare 1 Approved $1.79B 7
BEAM Beam Therapeutics HematologyMetabolic+1 Rare 1 Phase 2 $2.14B 6
ETON Eton Pharmaceuticals GI/HepatologyInfectious Disease+3 Rare 1 Approved $1.84B 17
MAZE Maze Therapeutics MetabolicRenal Rare 1 Phase 2 $1.80B 4